Metronidazole NDC 0713-0574

NDC codes

FDA NDC Directory

Product NDC (as listed)0713-0574Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00713-0574Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0713-0574-60	00713057460	1 TUBE in 1 CARTON (0713-0574-60) / 60 g in 1 TUBEMarketed from Feb 1, 2023

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Metronidazole
Generic name (nonproprietary): metronidazole
Active ingredients: Metronidazole — 10 mg/g
Dosage form: Gel
Route: Topical
Labeler: Cosette Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216692
Marketing start: Feb 1, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Nitroimidazoles (Chemical structure)
Identifiers: Product ID 0713-0574_f38e0e45-e6e7-84f3-e053-2995a90a197cSPL ID f38e0e45-e6e7-84f3-e053-2995a90a197cSPL set ID a0d7d4e8-28c0-4211-8d76-73a173b48d9aRxCUI 577237UNII 140QMO216E
Pharmacologic class: Nitroimidazole Antimicrobial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400713057460 followed by a unit qualifier and the quantity

Package 00713-0574-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 31, 2023.

Indications (excerpt from the label)

Metronidazole gel, 1% is indicated for the topical treatment of inflammatory lesions of rosacea. Metronidazole gel, 1% is a nitroimidazole indicated for the topical treatment of inflammatory lesions of rosacea.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)